I N THIS investigation, both a type of atherosclerosis and a type of medial arteriosclerosis were experimentally produced and studied. This approach is based upon the authors' basic premise that the etiology of these ateriopathies may be intimately interrlated, 1 a premise that is augmented by recently published observations. 2 ' '• 4 This report consists of observations made when employing adenosine triphosphate (ATP), adenosine monophosphate (AMP), and heparin, separately, in an endeavor to inhibit these scleroses. Lesions, essentially involving the tunica media, and not unlike human medial arteriosclerosis, were provoked in rabbits by the administration of epinephrine and thryoxine. 1 Atherosclerotic-like changes were experimentally produced by the intravenous administration of cholesterol suspensions. 6 The short time required for lesions to appear, their morphologic comparability to the human form, and the high incidence and severity of the arteriopathy make both the epinephrine-thyroxine and cholesterol methods satisfactory for inhibition studies. MATERIALS Between 0.05 and 0.01 Smaller than 0.01 Between 0.5 and 0.1 Smaller than 0.01 Significant or Not Significant Significant Significant Not Significant Significant * Previously reported. 1 f Chi Square values were obtained by utilizing the Fisher-Yates 2 X 2 contingency test. They refer exclusively to per cent incidence of sclerosis. A Probability value of 0.05 or less is usually considered to be significant, and indicates that the experimental data obtained were likely to have occurred by chance, one in twenty times or less frequency. Thus probability of 0.01 indicates a chance frequency of one in 100 times. 
ATP, AMP AND HEPAItIN IN EXPERIMENTAL ARTERIOPATHY
subcutuneously in the region of the middle of the buck, daily, for the fifteen days, at a constant dose level of 0.15 mg./Kg. of body weight.
Refrigerated, lyophilized ATP, sodium salt, was freshly prepared and administered immediately by subcutaneous injection, once a day, in a dose of 200 milligrams per animal. Similarly, AMP (E. Bischoff) was administered daily by subcutaneous injection in a dose of 40 mg. per rabbit. Repository heparin (Lederle), 2500 or 5000 U.S.P. Units, were injected subcutaneously in each rabbit so treated.
Each of these three substances were injected into two different groups of rabbits; one group concomitantly received the epinephrine-thyroxine regimen, the other receiving a concomitant cholesterol regimen. These injections followed the respective sclerogenic administration, by no less than one hour. Such injections were continued throughout the course of the sclerosis-inducing program, in a maximum of twenty days for the cholesterol type and a maximum of fifteen days for the epinephrine-thyroxine type.
In these experiments, animals failing to survive the sixth day of injections were eliminated from the final analysis. Post-mortem examinations were conducted on each animal. Our primary observations were concerned with the frequency and severity of macroscopic sclerosis in the aorta, from the region of the heart into the iliac bifurcation. Difficulty is encountered in such macroscopic gradation of sclerosis. However, for purposes of differentiation, we have undertaken their gradation on the following basis: (0) no patches, (1) single patches, (2) several patches, (3) scattered extensive patches, (4) widespread, confluent and extensive patches.
Microscopic studies of selected specimens, using hematoxylin-eosin and sudanophilic staining methods, were utilized.
RESULTS
The arteriopathy that results in epinephrinethyroxine injected rabbits is, as has been reported by Davis and Oester, 1 essentially medial and non-atheromatous. That which results with cholesterol injections is intimal and atheromatous. 6 In the epinephrine-thyroxine group, 43 out of 48 exhibited lesions (89.5 per cent). In the cholesterol series, 23 out of 32, or 71.8 per cent, showed lesions. Figure 1 illustrates each type of arteriopathy.
It will be noted that three distinct methods for judging gross evidence of lesions are employed. These are: (a) Per cent incidence; the ratio of animals with sclerosis over the total number of animals times 100. (b) Per cent of animals reaching the most severe degree of gross arteriopathy; that is, degree 3 or 4. (c) Severity factor, which is a number derived from the multiplication of the per cent incidence by the average degree of sclerosis (zero through 4) in a given treated group of animals. Table 1 and table 2 are summaries of the data obtained. ATP decreased the incidence and seventy of both forms of induced arteriopathy. Sclerosis was absent in 68 per cent of this group. AMP decreased, numerically, the incidence and severity of cholesterol-induced atherosclerosis, and was ineffective in the prevention of epinephrinethyroxine arteriopathy. This apparent effect on the cholesterol-induced sclerosis, however, was not of statistical significance. Heparin, on a numerical basis, produced a comparatively minor inhibition of both types of arteriopathy. The effects of heparin in the prevention of epinephrine-thyroxine sclerosis, on the basis of the chi square evaluation, were statistically significant; those against cholesterol-induced arteriopathy were not statistically significant.
DISCUSSION 1 AND CoxcLusroNS
In the pathogenesis of arterial sclerosis, degeneration of the ground (cement) substance commonly results. Structurally, the ground substance has, as important components, hyaluronic acid and chondroitin sulfuric acid. 6 These compounds have some similarity in chemical structure to heparin. The observations of the lipemia-clearing and antiatherogenic properties of heparin 7 prompted us to investigate the role of heparin in both the cholesterol and epinephrine-thyroxine induced arteriopathies.
Our interest and studies with adenosine triphosphate, at the inception of this work in 1950, were founded, in general, on the following considerations.
(1). Correlated with aging, rat myocardium shows an increasingly lower concentration of creatine phosphate. 3 This compound is a physiologic source of the high energy phosphatebonds vital to the chemical configuration auo biochemical activity of ATP.
(2). Deficiencies of cytoehrome C, alloxazine adenine dinucleotide, co-Enzyme I and co-Enzyme II in human arteriosclerotic aorta tissue, have been observed. 9 These hydrogen transport enzymes bear a relationship to ATP, in t h a t A T P formation results, physiologically, in close association with dehydrogenation reactions, especially in t h e tricarboxylic acid cycle of oxidative metabolism.
(3). A T P injections actively lower blood pressure and produce general vascular dilation. Removal of the adrenal medulla sensitizes the animal to A T P shock. This m a y be indication of an antagonism between A T P and epinephrine. 10 (4). Adenosine, a known precursor t o A T P , produces coronary dilation. 11 (5). A T P produces direct myocardial effects such as AV delay and SA block in man. These bear directly on cardiac output and oxygenation of arteries. 12 Since t h e beginnings of this study, additional published data h a s served t o maintain and further our interest in A T P . Thus, A M P , a physiologic precursor t o A T P , h a s been observed to prevent spontaneous atherogenesis in chicks. 13 More recently, dilation of t h e coronaries in dogs, b y A T P in doses of less than one microgram, h a s been observed. 14 Perhaps of more current interest is t h e observation that A T P effectively maintains the colloid stability of serum from patients with arteriosclerosis. Abnormal lowering of serum colloid stability in human arteriosclerosis was recently reported. 16 A T P proved, unequivocally, t h e most potent inhibitor tested. I t outranks b y far the inhibition produced with heparin or A M P , or a n y other compound tested in our laboratory such as inositol, 1 ascorbic acid, 1 progesterone and alpha tocopherol.
The pharmacologic influences of A T P , coronary dilation, lowering of blood pressure and myocardial effects, plus its role in t h e stability of colloids of serum, cannot be overlooked in seeking a mechanism of action for this striking effect.
SUMMARY
Heparin sodium was tested for its effect on experimental arteriopathy of t h e cholesterol and epinephrine-thyroxine induced types. I t was found t o lower t h e incidence a n d severity of both forms. However, this effect had biometric significance only against t h e epinephrine-thyroxine arteriopathy.
Adenosine monophosphate was found less effective than heparin against epinephrinethyroxine, b u t about t h e same as heparin against t h e cholesterol sclerosis. Again, these findings were n o t of biometric significance.
ATP, used in both t h e epinephrine-thyroxine a n d cholesterol forms of arteriopathy, produced a notable inhibitory influence in each case. These results were statistically significant.
